Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PK study of TAK-272 in subjects with renal or hepatic impairment
jRCT2080222738Phase 1
- Sponsor
- Takeda
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of imarikiren in hypertension (HTN) (5 arms), sponsored by Takeda.
02
Drugs
imarikiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080222738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222738.